MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data
πππππ/ππππ: ππ₯π’π§π’πππ₯ ππ§π πππ¨π§π¨π¦π’π π
π’π§ππ’π§π π¬ ππ«π¨π¦ 40-π²πππ« π
π¨π₯π₯π¨π°-ππ© ππππ
On Tuesday December 10th, Quantifyβs Emilie Toresson Grip is one of three speakers at ISPORβs webinar on MASLD/ MASH following their BRIDGE-MASH study.
Moderated by Riku Ota, Global Payer Evidence Lead at [β¦]
